THL Partners will acquire Celerion from H.I.G. Capital for $1.8 billion, according to news releases and industry reports.
Celerion, formed in 2010 and based in Lincoln, Nebraska, is a global provider of clinical pharmacology and bioanalytical sciences.
THL, founded in 1974 and based in Boston, is a private equity firm investing in